. . . . . . . "[Patients with 5?-reductase 2 (5?-RD2) and 17?-hydroxysteroid dehydrogenase 3 (17?-HSD3) deficiencies exhibit the highest rates of gender dysphoria (incidence of up to 63%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:13:29+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .